Previous study has demonstrated that Hdac3-specific inhibitor MS-275 protects β-cells against cytokine-induced apoptosis in type 1 diabetes (Chou et al. 2012), as well as from palmitate-induced cell death in diabetes (Plaisance et al. 2014). This evidence concerns the gene HDAC3 and type 1 diabetes mellitus.